(Q41493817)

English

Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis

scientific article published on March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

object named as

Bruno Delafont

3

0 references

object named as

William MacNee

15

0 references

Ruth Tal-Singer

4

object named as

Ruth Tal-Singer

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Emiel F M Wouters

16

object named as

Emiel F M Wouters

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

author name string

Stephen I Rennard

1

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Nicholas Locantore

2

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Edwin K Silverman

5

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Jørgen Vestbo

6

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Bruce E Miller

7

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Per Bakke

8

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Bartolomé Celli

9

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Peter M A Calverley

10

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Harvey Coxson

11

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Courtney Crim

12

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Lisa D Edwards

13

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

David A Lomas

14

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Julie C Yates

17

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Ignacio Coca

18

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Alvar Agustí

19

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints

20

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

publication date

1 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Proceedings of the American Thoracic Society

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

303-312

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Characterisation of COPD heterogeneity in the ECLIPSE cohort

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Unsupervised Learning With Random Forest Predictors

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

The return of the minimum clinically important difference for 6-minute-walk distance in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Issues concerning health-related quality of life in COPD.

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Cluster Analysis

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201403-125OC

21 January 2018

Identifiers

10.1513/ANNALSATS.201403-125OC

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41493817&oldid=1922300121"